NCT04617470View on ClinicalTrials.gov

Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study

UnknownOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

July 8, 2020

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2022

Conditions

Ovarian Cancer

Trial Locations (1)

00168

RECRUITING

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT04617470 - Niraparib as Maintenance Treatment in Platinum Responsive Ovarian Cancer Patients: a Real Life Study | Biotech Hunter | Biotech Hunter